MORPHOSYS AG O.N. - Daily - Technical analysis published on 11/04/2019 (GMT)
- 244
- 0
- Who voted?
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
Summary of the analysis
Additional analysis
Quotes
The MORPHOSYS AG O.N. price is 101.70 EUR. The price has increased by +1.60% since the last closing and was traded between 99.10 EUR and 102.20 EUR over the period. The price is currently at +2.62% from its lowest and -0.49% from its highest.The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by MORPHOSYS AG O.N.:
Technical
Technical analysis of MORPHOSYS AG O.N. in Daily shows an overall slightly bullish trend. 57.14% of the signals given by moving averages are bullish. The slightly bullish signals given by short-term moving averages do not show a strengthening of this global trend. An assessment of moving averages reveals several bullish signals that could impact this trend:
Bullish trend reversal : adaptative moving average 20
Type : Bullish
Timeframe : Daily
Bullish trend reversal : adaptative moving average 100
Type : Bullish
Timeframe : Daily
Bullish price crossover with Moving Average 20
Type : Bullish
Timeframe : Daily
Bullish price crossover with adaptative moving average 100
Type : Bullish
Timeframe : Daily
In fact, 10 technical indicators on 18 studied are currently positioned bullish. Central Indicators, the scanner specialised in technical indicators, has identified these signals:
MACD crosses UP its Moving Average
Type : Bullish
Timeframe : Daily
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
Williams %R indicator is back over -50
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Near horizontal support
Type : Bullish
Timeframe : Daily
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 86.72 | 90.55 | 96.40 | 101.70 | 104.10 | 110.10 | 113.80 |
Change (%) | -14.73% | -10.96% | -5.21% | - | +2.36% | +8.26% | +11.90% |
Change | -14.98 | -11.15 | -5.30 | - | +2.40 | +8.40 | +12.10 |
Level | Major | Intermediate | Major | - | Major | Minor | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 91.52 | 94.63 | 97.37 | 100.48 | 103.22 | 106.33 | 109.07 |
Camarilla | 98.49 | 99.03 | 99.56 | 100.10 | 100.64 | 101.17 | 101.71 |
Woodie | 91.33 | 94.54 | 97.18 | 100.39 | 103.03 | 106.24 | 108.88 |
Fibonacci | 94.63 | 96.87 | 98.25 | 100.48 | 102.72 | 104.10 | 106.33 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 79.68 | 85.17 | 92.63 | 98.12 | 105.58 | 111.07 | 118.53 |
Camarilla | 96.54 | 97.73 | 98.91 | 100.10 | 101.29 | 102.47 | 103.66 |
Woodie | 80.68 | 85.66 | 93.63 | 98.61 | 106.58 | 111.56 | 119.53 |
Fibonacci | 85.17 | 90.11 | 93.17 | 98.12 | 103.06 | 106.12 | 111.07 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 74.72 | 82.68 | 90.17 | 98.13 | 105.62 | 113.58 | 121.07 |
Camarilla | 93.40 | 94.82 | 96.23 | 97.65 | 99.07 | 100.48 | 101.90 |
Woodie | 74.48 | 82.56 | 89.93 | 98.01 | 105.38 | 113.46 | 120.83 |
Fibonacci | 82.68 | 88.59 | 92.23 | 98.13 | 104.04 | 107.68 | 113.58 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 49.50 | |
MACD (12,26,9): | -0.7600 | |
Directional Movement: | -0.89 | |
AROON (14): | -35.72 | |
DEMA (21): | 98.62 | |
Parabolic SAR (0,02-0,02-0,2): | 103.60 | |
Elder Ray (13): | 1.07 | |
Super Trend (3,10): | 104.36 | |
Zig ZAG (10): | 100.00 | |
VORTEX (21): | 1.0500 | |
Stochastique (14,3,5): | 55.66 | |
TEMA (21): | 98.84 | |
Williams %R (14): | -39.48 | |
Chande Momentum Oscillator (20): | 0.35 | |
Repulse (5,40,3): | -1.5400 | |
ROCnROLL: | -1 | |
TRIX (15,9): | -0.1400 | |
Courbe Coppock: | 0.86 |
MA7: | 98.69 | |
MA20: | 99.38 | |
MA50: | 102.41 | |
MA100: | 100.64 | |
MAexp7: | 99.26 | |
MAexp20: | 99.79 | |
MAexp50: | 100.99 | |
MAexp100: | 99.92 | |
Price / MA7: | +3.05% | |
Price / MA20: | +2.33% | |
Price / MA50: | -0.69% | |
Price / MA100: | +1.05% | |
Price / MAexp7: | +2.46% | |
Price / MAexp20: | +1.91% | |
Price / MAexp50: | +0.70% | |
Price / MAexp100: | +1.78% |
News
The latest news and videos published on MORPHOSYS AG O.N. at the time of the analysis were as follows:
- DGAP-News: MorphoSys AG Reports Third Quarter 2019 Financial Results
- DGAP-News: MorphoSys AG: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone
- DGAP-Adhoc: MorphoSys AG: Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone
- MorphoSys AG Reports Third Quarter 2019 Financial Results
- DGAP-News: MorphoSys AG: MOR106 Clinical Development in Atopic Dermatitis Stopped
Add a comment
Comments
0 comments on the analysis MORPHOSYS AG O.N. - Daily